Integrated Efficacy of FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Analyses of Efficacy in Clinically Relevant Subgroups of Patients. (2020). SKIN The Journal of Cutaneous Medicine, 4(6), s89. https://doi.org/10.25251/skin.4.supp.89